JSW-Research

JSW Life Sciences, now operating as QPS Austria, is a specialized contract research organization (CRO) focused on neurodegenerative diseases and rare disorders. The company provides a comprehensive suite of preclinical and clinical services, with a particular emphasis on central nervous system (CNS) research. They are globally recognized for their extensive portfolio of transgenic and non-transgenic in vivo models for Alzheimer's, Parkinson's, and Huntington's disease. Following its acquisition by QPS in 2014, the firm serves as a center of excellence for CNS drug discovery and development within a global network. Their expertise includes behavioral testing, neurohistology, and biochemical analysis to support drug efficacy and safety studies. The facility in Austria is GLP and GCP compliant, ensuring high-quality data for regulatory submissions.